Intraobserver and Interobserver Variations in Liver Biopsy
Interpretation in Patients with Chronic Hepatitis C
Authors: The French METAVIR Cooperative Study Group.
Journal: Hepatology 1994 Jul;20(1 Pt 1):15-20
Liver biopsy is used as the "gold standard" for the assessment of the stage and degree
of activity in chronic Hepatitis C and is of major importance in evaluating
the effects of treatment. Because numerous therapeutic trials are undertaken
with histological control, the reproducibility of liver biopsy interpretation
appears essential.
Therefore the aim of this study was to estimate intraobserver and interobserver
variations in the assessment of features, classification, and numerical scoring
of chronic viral Hepatitis C among 10 pathologists specializing in liver diseases.
These pathologists independently reviewed 30 liver biopsy specimens of viral
Hepatitis C and completed a histological form for each of the specimens. Five
pairs of pathologists then were randomly designated. They independently reviewed
the biopsy specimens and filled out a new coding form. The interobserver variation
was calculated for each item among the 10 individuals and then among the five
pairs with the intraclass correlation coefficient or kappa statistics. Five
features showed an almost perfect or a substantial degree of concordance
among the 10 observers (i.e., cirrhosis, fibrosis, fibrosis grading of Knodell index, steatosis,
portal lymphoid aggregates). The 17 other indicators showed a weaker concordance
with, for instance, a moderate degree of concordance for piecemeal necrosis,
disease activity, Knodell index, a
fair degree of concordance for lobular necrosis, and only a slight degree of
concordance for six items. Five items had a higher concordance when viewed by
a pair of pathologists than when studied by only one pathologist (i.e., steatosis,
periportal necrosis grading of Knodell index, lobular
necrosis grading of Knodell index, centrilobular
fibrosis, and ductular proliferation).
Site Topics
Frequently Asked Questions
Some of our most commonly asked questions and our answers to them.
HCV Symptoms
You'll find links to a comprehensive symptoms list, as well as various studies and discussions about Hepatitis C symptoms.
Lab Tests
What they are and what they mean. Helps you interpret & understand all the various hepatitis lab tests likely to be encountered.
Hepatitis C Genotypes
Learn about Hepatitis C Genotypes and their variants.
Viral Load
Provides detailed information on how to analyze and interpret viral load numbers as well as a link to a convenient Viral Load Chart.
What is...?
Learn more about various Hepatitis C related topics, including HCV, Ascites, Biopsies, and much more.
HCV Medicines
Numerous links to studies, info sheets, FAQs, and analysis of Ribavirin/Rebetron medicines.
Glossary
Commonly used medical terms and definitions.
Hepatitis C Doctors
A state-by-state and worldwide reference listing physicians who treat HCV, including an email link to submit your physician for inclusion.
Biopsy Info
A comprehensive resource of information relating to the liver biopsy.
Cirrhosis
Many discussions and analyses of cirrhosis, including causes, complications, pathology, symptoms, and much more.
Liver Cancer
Liver Cancer/Hepatocellular Carcinoma studies, info sheets, FAQs, and analysis.
Liver Disease Medicines
An exhaustive list of links to studies, info sheets, FAQs, and analysis of the various drugs used to treat liver disease.
Hep-Central Email List
Sign up to learn about advances and breakthroughs in Hepatitis C research, including information about medical and complementary treatments.
HCV Links
Convenient links to other sites external to Hepatitis-Central.
-
HCV Transmission
Information about the transmission of Hepatitis C.
HCV Natural Remedies
A number of herbal products useful in the management of liver disease.
HCV Books
Recommended reading for those interested in hepatitis information.
Hepatitis C Forum
A Bulletin Board for discussions on hepatitis, treatments, etc.
Hepatitis C Activism
An easy way to get involved in urging our government to do more for Hepatitis C awareness and treatment research.

